Subtopic Deep Dive
Mitochondrial Permeability Transition Pore
Research Guide
What is Mitochondrial Permeability Transition Pore?
The mitochondrial permeability transition pore (mPTP) is a non-specific channel in the inner mitochondrial membrane that opens during cardiac reperfusion, causing mitochondrial swelling, uncoupling, and cell death.
mPTP opening is triggered by calcium overload and oxidative stress post-ischemia. It mediates reperfusion injury by releasing cytochrome c and disrupting ATP production. Over 10,000 citations across key papers document its role in cardioprotection strategies (Hausenloy and Yellon, 2013; Halestrap, 2003).
Why It Matters
mPTP inhibition reduces infarct size in myocardial infarction models, offering a therapeutic target beyond timely reperfusion (Hausenloy and Yellon, 2013; Halestrap, 2003). Cyclosporin A blocks mPTP to protect human hearts during postconditioning (Staat et al., 2005). Targeting mPTP components like GSK-3β converges protective signals to prevent pore opening (Juhaszova et al., 2004). This limits cell death in ischemia-reperfusion, impacting heart attack treatments worldwide.
Key Research Challenges
Identifying mPTP Components
Debate persists on exact proteins forming mPTP despite candidates like ANT and cyclophilin D. Halestrap (2009) reviews evidence but notes unresolved structure. Genetic knockouts yield conflicting cardioprotection results (Baines et al., 2012).
Regulating Pore Opening Triggers
Calcium and ROS thresholds for mPTP opening vary by ischemic duration and species. Zorov et al. (2006) describe ROS-induced ROS release amplifying triggers. Murphy and Steenbergen (2008) highlight pH and matrix calcium interplay complicating inhibition.
Translating Inhibitors Clinically
mPTP blockers like cyclosporin show promise in animals but limited human efficacy due to dosing and side effects. Hausenloy and Yellon (2013) note neglected therapeutic potential. Ong et al. (2010) link fission inhibitors to mPTP protection, yet trials lag.
Essential Papers
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy, Derek M. Yellon · 2013 · Journal of Clinical Investigation · 2.2K citations
Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and limiting MI size ...
Cell Biology of Ischemia/Reperfusion Injury
Theodore J. Kalogeris, Christopher Baines, Maike Krenz et al. · 2012 · International review of cell and molecular biology · 2.1K citations
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Elizabeth Murphy, Charles Steenbergen · 2008 · Physiological Reviews · 1.4K citations
Mitochondria play an important role in cell death and cardioprotection. During ischemia, when ATP is progressively depleted, ion pumps cannot function resulting in a rise in calcium (Ca 2+ ), which...
Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection
Andrew P. Halestrap · 2003 · Cardiovascular Research · 1.2K citations
Reperfusion of the heart after a period of ischaemia leads to the opening of a nonspecific pore in the inner mitochondrial membrane, known as the mitochondrial permeability transition pore (MPTP). ...
Mitochondrial ROS-induced ROS release: An update and review
Dmitry B. Zorov, Magdalena Juhaszova, Steven J. Sollott · 2006 · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 1.1K citations
Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
Magdalena Juhaszova, Dmitry B. Zorov, Suhn-Hee Kim et al. · 2004 · Journal of Clinical Investigation · 988 citations
Environmental stresses converge on the mitochondria that can trigger or inhibit cell death. Excitable, postmitotic cells, in response to sublethal noxious stress, engage mechanisms that afford prot...
Postconditioning the Human Heart
Patrick Staat, Gilles Rioufol, Christophe Piot et al. · 2005 · Circulation · 973 citations
Background— In animal models, brief periods of ischemia performed just at the time of reperfusion can reduce infarct size, a phenomenon called postconditioning. In this prospective, randomized, con...
Reading Guide
Foundational Papers
Start with Halestrap (2003) for mPTP opening mechanics during reperfusion; Hausenloy and Yellon (2013) for clinical context; Murphy and Steenbergen (2008) for Ca2+ mechanisms.
Recent Advances
Cadenas (2018) on ROS signaling; Ong et al. (2010) on fission-mPTP links; extend to post-2013 clinical trials via citationGraph.
Core Methods
Cyclosporin A inhibition, isolated mitochondria swelling assays, cyclophilin D knockouts, ROS fluorescence imaging, postconditioning protocols.
How PapersFlow Helps You Research Mitochondrial Permeability Transition Pore
Discover & Search
Research Agent uses searchPapers('mitochondrial permeability transition pore cardiac reperfusion') to retrieve Halestrap (2003) with 1198 citations, then citationGraph to map forward citations like Juhaszova et al. (2004), and findSimilarPapers for related ROS mechanisms from Zorov et al. (2006). exaSearch uncovers niche reviews on mPTP structure.
Analyze & Verify
Analysis Agent applies readPaperContent on Halestrap (2006) to extract pore opening mechanisms, verifyResponse with CoVe against Murphy and Steenbergen (2008) for calcium claims, and runPythonAnalysis to plot citation trends or ROS dose-responses from extracted data using pandas/matplotlib. GRADE grading scores evidence strength for clinical translation claims.
Synthesize & Write
Synthesis Agent detects gaps in mPTP inhibitor trials post-Hausenloy (2013), flags contradictions between genetic models (Kalogeris et al., 2012), and generates exportMermaid diagrams of signaling convergence to mPTP (Juhaszova et al., 2004). Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ references, and latexCompile for polished reviews.
Use Cases
"Analyze calcium-ROS interaction data from mPTP papers to model pore opening thresholds."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Zorov 2006, Murphy 2008) → runPythonAnalysis (pandas curve fitting on extracted thresholds) → matplotlib plot of dose-response.
"Write a review section on mPTP inhibitors with citations and signaling diagram."
Synthesis Agent → gap detection (post-Halestrap 2003) → Writing Agent → latexEditText (draft text) → latexSyncCitations (Hausenloy 2013 et al.) → exportMermaid (GSK-3β pathway) → latexCompile (PDF output).
"Find GitHub code for mPTP simulations in ischemia models."
Research Agent → searchPapers('mPTP simulation cardiac') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (ROS-calcium ODE models) → runPythonAnalysis (re-run simulation sandbox).
Automated Workflows
Deep Research workflow scans 50+ mPTP papers via searchPapers and citationGraph, producing structured reports on inhibitors with GRADE scores. DeepScan's 7-step chain verifies claims across Halestrap (2009) and Juhaszova (2004) with CoVe checkpoints. Theorizer generates hypotheses on mPTP-fission links from Ong et al. (2010) data.
Frequently Asked Questions
What defines the mitochondrial permeability transition pore?
mPTP is a non-specific inner membrane channel opening on reperfusion, triggered by Ca2+ and ROS overload, leading to mitochondrial dysfunction (Halestrap, 2003).
What are key methods to study mPTP in cardiac reperfusion?
Cyclosporin A inhibits mPTP for functional assays; genetic knockouts target cyclophilin D; ROS scavengers isolate triggers (Juhaszova et al., 2004; Zorov et al., 2006).
What are seminal papers on mPTP?
Halestrap (2003, 1198 citations) establishes mPTP as cardioprotection target; Hausenloy and Yellon (2013, 2235 citations) reviews therapeutic neglect; Murphy and Steenbergen (2008, 1403 citations) details mechanisms.
What open problems exist in mPTP research?
Uncertain molecular composition despite ANT/cyclophilin D roles (Halestrap, 2009); variable inhibitor efficacy in humans (Staat et al., 2005); interplay with fission dynamics (Ong et al., 2010).
Research Cardiac Ischemia and Reperfusion with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mitochondrial Permeability Transition Pore with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiac Ischemia and Reperfusion Research Guide